1. Plerixafor in combination with granulocyte–colony‐stimulating factor after chemotherapy increases mobilization efficiency in patients with lymphoma or myeloma: results of a Phase II clinical trial. Issue 10 (2nd September 2015) Authors: Jagirdar, Neera; Harvey, R. Donald; Nooka, Ajay; Flowers, Christopher; Kaufman, Jonathan; Lonial, Sagar; Lechowicz, Mary Jo; Langston, Amelia; Lipscomb, Carol; Gaylor, Cynthia; Waller, Edmund K. Journal: Transfusion Issue: Volume 55:Issue 10(2015) Page Start: 2351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗